Diagnostic Consultation Center XX-Sofia EOOD

At Diagnostic Consultation Center XX-Sofia EOOD, cardiovascular research focuses on atrial fibrillation and the prevention of stroke and systemic embolism. These studies are designed to compare treatment options and better understand how to balance effectiveness with safety for people at risk of serious clot-related complications.

• Prevention of stroke and systemic embolism in atrial fibrillation
• Evaluating treatment effectiveness and bleeding risk in heart rhythm disorders

This area reflects a strong interest in improving care for patients with cardiovascular disease through safer and more effective long-term treatment choices.

Research in digestive system diseases centers on cholestasis and primary biliary cholangitis, with a focus on relieving cholestatic pruritus. The trials aim to assess whether new therapy options can improve comfort and support better symptom control over time.

• Cholestasis and cholestatic itching in primary biliary cholangitis
• Testing a new approach to improve symptom relief and long-term tolerability

This work highlights the site’s role in exploring treatments that may help people living with chronic liver and bile duct disorders.

The site also conducts studies in immune system diseases, especially alopecia areata, an autoimmune condition that causes sudden hair loss. Research here is aimed at evaluating new therapies that may reduce symptoms and improve hair regrowth while maintaining safety in both adults and adolescents.

• Severe alopecia areata in adults and adolescents
• Assessing a potential treatment for symptom improvement and longer-term disease control

This therapeutic area shows a clear interest in autoimmune disease care and in finding better options for patients affected by visible, life-impacting conditions.

In the field of nutritional and metabolic diseases, research at this Sofia site includes severe hypertriglyceridemia. The clinical trials are focused on lowering very high triglyceride levels and evaluating whether new treatment approaches can improve metabolic health.

• Severe hypertriglyceridemia
• Studying a therapy intended to reduce triglycerides and support cardiovascular risk management

This area connects metabolic disorder research with broader efforts to prevent complications linked to abnormal blood fat levels.